Browse by author
Lookup NU author(s): Professor Andrew FisherORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Lung transplantation offers a major survival benefit in selected patients with end-stage pulmonary disease. In recent years, there is accumulating evidence of an increase in solid organ tumors and especially in primary lung cancer. There is also some anecdotal evidence that lung transplantation may be beneficial as a treatment option in some patients with lung cancer, such as the ones with extensive bronchoalveolar cell carcinoma. In this review, we analyze the literature data reporting the incidence of lung cancer after lung transplantation with its inherent risk factors, and we summarize the available data on possible treatment of lung cancer by lung transplantation. Finally, bronchial epithelial chimerism as possible cause for lung cancer is discussed. Copyright (C) 2011 S. Karger AG, Basel
Author(s): Verleden GM, Fisher AJ
Publication type: Review
Publication status: Published
Journal: Respiration
Year: 2011
Volume: 81
Issue: 6
Pages: 441-445
Print publication date: 16/05/2011
ISSN (print): 0025-7931
ISSN (electronic): 1423-0356
Publisher: KARGER
URL: http://dx.doi.org/10.1159/000326934
DOI: 10.1159/000326934